CGON
Price
$23.14
Change
-$1.35 (-5.51%)
Updated
Apr 1, 02:32 PM (EDT)
Capitalization
2.01B
37 days until earnings call
ZURA
Price
$1.15
Change
-$0.14 (-10.85%)
Updated
Apr 1, 02:54 PM (EDT)
Capitalization
86.49M
Ad is loading...

CGON vs ZURA

Header iconCGON vs ZURA Comparison
Open Charts CGON vs ZURABanner chart's image
CG Oncology
Price$23.14
Change-$1.35 (-5.51%)
Volume$534
Capitalization2.01B
Zura Bio
Price$1.15
Change-$0.14 (-10.85%)
Volume$1K
Capitalization86.49M
CGON vs ZURA Comparison Chart
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. ZURA commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and ZURA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (CGON: $24.49 vs. ZURA: $1.29)
Brand notoriety: CGON and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 207% vs. ZURA: 117%
Market capitalization -- CGON: $2.01B vs. ZURA: $86.49M
CGON [@Biotechnology] is valued at $2.01B. ZURA’s [@Biotechnology] market capitalization is $86.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 4 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 4 bullish, 5 bearish.
  • ZURA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZURA is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -14.16% price change this week, while ZURA (@Biotechnology) price change was -4.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.02%. For the same industry, the average monthly price growth was -12.29%, and the average quarterly price growth was -11.18%.

Reported Earning Dates

CGON is expected to report earnings on May 08, 2025.

ZURA is expected to report earnings on Mar 28, 2023.

Industries' Descriptions

@Biotechnology (-8.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.01B) has a higher market cap than ZURA($86.5M). CGON YTD gains are higher at: -14.609 vs. ZURA (-48.400). ZURA has higher annual earnings (EBITDA): -50.28M vs. CGON (-95.94M). CGON has more cash in the bank: 541M vs. ZURA (188M). CGON has higher revenues than ZURA: CGON (684K) vs ZURA (0).
CGONZURACGON / ZURA
Capitalization2.01B86.5M2,325%
EBITDA-95.94M-50.28M191%
Gain YTD-14.609-48.40030%
P/E RatioN/A7.96-
Revenue684K0-
Total Cash541M188M288%
Total Debt296KN/A-
TECHNICAL ANALYSIS
Technical Analysis
CGONZURA
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
40%
Advances
ODDS (%)
Bullish Trend 21 days ago
75%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
55%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGENF2.000.16
+8.70%
NervGen Pharma Corp.
KCDMY8.360.05
+0.60%
Kimberly-Clark de Mexico, S.A.B de C.V.
LGGNY16.090.08
+0.50%
Legal & General Group Plc
GMBL0.23N/A
N/A
Esports Entertainment Group, Inc.
WMMVY27.55-0.41
-1.47%
Wal-Mart De Mexico S.A.B. de C.V.

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-7.31%
SYRE - CGON
48%
Loosely correlated
-10.06%
KRYS - CGON
45%
Loosely correlated
-1.97%
IDYA - CGON
44%
Loosely correlated
-3.93%
ACLX - CGON
43%
Loosely correlated
-3.47%
OLMA - CGON
42%
Loosely correlated
-8.52%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with CGON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
+1.98%
CGON - ZURA
37%
Loosely correlated
-7.31%
SYRE - ZURA
36%
Loosely correlated
-10.06%
CGEM - ZURA
35%
Loosely correlated
-5.61%
IMUX - ZURA
32%
Poorly correlated
-9.17%
DNA - ZURA
31%
Poorly correlated
-6.86%
More